Vaidya Sane Ayurved Laboratories (NSE: MADHAVBAUG) is a Thane, Maharashtra-based company in the Health Care Distributors industry. With a market capitalisation of ₹169 Cr, it ranks #2,802 by market cap among the 6,137 Indian listed companies on FinBizNet, and #2 of 11 in Health Care Distributors. The share price is down 43.5% over one year and down 27.5% over three months.
| Market Cap | ₹169 Cr |
|---|---|
| NSE Symbol | MADHAVBAUG |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Distributors |
| Return on Equity | 11.99% |
| Return on Assets | 6.33% |
| 52-Week Range | ₹140.00 – ₹335.00 |
| 1-Year Price Change | -43.5% |
| 3-Month Price Change | -27.5% |
| Headquarters | Thane, Maharashtra |
| Website | madhavbaug.org |
Vaidya Sane Ayurved Laboratories Limited, together with its subsidiaries, distributes ayurvedic medicines and products in India. It operates through Sale of Product and Hospital Activity segments. The company sells medicines for arthritis and joint pains, cholesterol, diabetes, digestive, acidity, gastric, dyslipidemia, fever, cough, cold, general tonic, heart disease, hypertension/high blood pressure, liver, low glycemic index atta, obesity/weight management, piles and renal, skin, and wounds; and diet boxes, glow gorgeous cosmetics, health supplements, healthy breakfast, laxatives, low fat oil, immunity boosters, nutri snacks, and stevia products through its clinics and online shop. It is also involved in the operation of owned and franchised clinics; and cardiac prevention and rehabilitation hospitals. In addition, the company offers services in the areas of heart disease reversal, diabetes reversal, blood pressure management and hypertension, obesity management, and joint pain care
1. Hospital Activity-This segment operates medical service institutions to treat chronic ailments, such as cardiac disease, diabetes, hypertension, and obesity. 2. Sale of Product Activity-This segment engages in the procurement and sale of medicines, medical equipment and consumables, etc. 3. Common/Unallocable-0 4. Pharmaceuticals-This segment operates cardiac care clinics and hospitals.
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Trimurthi Ltd | ₹181 Cr | 53.1 | 7.99% | — | +48.6% |
| Vaidya Sane Ayurved Laboratories | ₹169 Cr | — | 11.99% | — | -43.5% |
| Achyut Healthcare Ltd | ₹139 Cr | 463.1 | 0.95% | — | +15.0% |
| Balaxi Pharmaceuticals Ltd | ₹122 Cr | 85.9 | 0.59% | ₹81 Cr | -50.2% |
| Chanfta Bhagat Pharma Ltd | ₹30 Cr | 9.9 | 2.91% | — | -5.1% |
| Medico Intercontinental Ltd | ₹25 Cr | -7.8 | -27.14% | ₹14 Cr | -34.9% |
| Zenlabs Ethica Ltd | ₹18 Cr | -10.1 | -20.44% | — | -12.8% |
| Rubra Medicaments Ltd. | ₹18 Cr | 11.9 | 12.67% | — | -37.7% |
| Nexus Surgical & Medicare Ltd | ₹17 Cr | 21.7 | 51.41% | — | +76.5% |
Listed by market capitalisation. Ratios are shown for context only.
Vaidya Sane Ayurved Laboratories operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Distributors).
Vaidya Sane Ayurved Laboratories has a return on equity of 11.99%.
Vaidya Sane Ayurved Laboratories is listed on the NSE under the symbol MADHAVBAUG.
Vaidya Sane Ayurved Laboratories's share price is down 43.5% over one year and down 27.5% over three months. Its 52-week range is ₹140.00 to ₹335.00.
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.